BTG's growing portfolio of Interventional Medicine products is designed to advance the treatment of cancer, severe emphysema, severe blood clots, and varicose veins, whilst their Specialty Pharmaceuticals portfolio offers antidotes that alleviate toxicity and treat rare conditions.
Healthcare is constantly evolving – so BTG never stands still. Inspired by a deep understanding of their customers’ needs, they are working to meaningfully improve the lives of patients and their healthcare experience.
BTG's competitive advantage is our dedication to finding smart, often unconventional solutions to complex medical problems. Many of our products combine medicines, device technology and new techniques in order to deliver more targeted treatments.
See our website here
BTG acquired Galil Medical in May 2016
Dr Phil Haslam, Which Medical Device Editor-in-Chief, took a look at BTG's Visual-ICE system at the BSIR 2017 annual scientific meeting held in Birmingham's ICC UK) in November. It's a mobile system intended for cryoablative tissue destruction using a minimally invasive...
read full descriptionWhichMedicalDevice is a FREE resource created by clinicians for clinicians.
Registration is free and gives you unlimited access to all of the content and features of this website.
Find out more...Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...
Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.
We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.